Annette Stemhagen, DrPH, FISPE, Senior Vice President & Chief Science Officer of Safety, Epidemiology, Registries & Risk Management, UBC
Dr. Stemhagen discusses using a Real-world Evidence strategy in clinical development, the practical applications of RWE, the long-term results of RWE, and trends seen while at DIA.
For more information please visit www.ubc.com.
Matt Giegerich, CEO, The Inception Company
Shaun Urban, President, The Inception Company
John Nosta, Founder, NostaLab (Moderator)
Sharon Callahan, CEO, TBWAWorldHealth; Chief Client Officer, Omnicom Health Group
Patrick Lindsay, President, United BioSource Corporation
Wendy White, Chief Patient Officer, Vitrisa Therapeutics
Ben Wiegand, Ph.D., Global Head, World Without Disease Accelerator, Janssen Pharmaceutical Companies of Johnson & Johnson
A variety of industry visionaries
Dan Limbach - Producer, PharmaVOICE Webcast Network
Dan Limbach, Producer - PharmaVOICE Webcast Network
